ロード中...
RNA-Based Therapeutics: From Antisense Oligonucleotides to miRNAs
The first therapeutic nucleic acid, a DNA oligonucleotide, was approved for clinical use in 1998. Twenty years later, in 2018, the first therapeutic RNA-based oligonucleotide was United States Food and Drug Administration (FDA) approved. This promises to be a rapidly expanding market, as many emergi...
保存先:
| 出版年: | Cells |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7016530/ https://ncbi.nlm.nih.gov/pubmed/31936122 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells9010137 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|